Prestige Biologics Co., Ltd. (KOSDAQ: A334970)
Health Care · Biotechnology · KR
₩1,408.00
-1.81% today · -56.1% 1Y
Prestige Biologics Co., Ltd. (KOSDAQ: A334970) operates in the Biotechnology industry within the Health Care sector. The company is valued at $81.43M.
Over the last twelve months the share price has lost 56.1%, trading between 1.23K and 3.85K.
Tweenvest scores Prestige Biologics Co., Ltd. across four factors: quality 24/100, value 37/100, growth 100/100. Its strongest factor is growth.
A334970 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $81.43M
- Revenue (TTM)
- $17.22M
- P/E
- —
- EPS
- -658.76
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- ₩3,850.00
- 52-week low
- ₩1,230.00
- Avg volume (3M)
- —
- Shares outstanding
- 77.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Allied Biotech CorporationTPEX: 1780 | $84.09M | NT$24.65 | -2.76% |
| Cardiff Oncology, Inc.NasdaqCM: CRDF | $84.02M | $1.01 | -6.48% |
| 3D Global Biotech Inc.TPEX: 6808 | $83.18M | NT$34.55 | +1.62% |
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $81.85M | $1.75 | -8.38% |
| BIONET Therapeutics Corp.TPEX: 7808 | $81.00M | NT$37.00 | -8.64% |
| Sera Prognostics, Inc.NasdaqGM: SERA | $80.48M | $2.06 | +0.74% |
| Greenland Mines LtdNasdaqCM: GRML | $80.35M | $5.50 | -8.72% |
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
Figures last refreshed Oct 11, 2026.